European Commission, EMA and HTA issue harmonized guidance for clinical trials during the COVID-19 pandemic
This guidance includes a harmonised set of recommendations, to ensure the utmost safety of trial participants across the European Union while preserving the quality of the data generated by the trials. It also advises how these changes should be [...]
















